Literature DB >> 20663564

A strong genetic association between the tumor necrosis factor locus and proliferative vitreoretinopathy: the retina 4 project.

Jimena Rojas1, Itziar Fernandez, Jose C Pastor, Maria T Garcia-Gutierrez, Maria R Sanabria, Maria Brion, Rosa M Coco, Jose M Ruiz-Moreno, Jose Garcia-Arumi, Javier Elizalde, Miguel Ruiz-Miguel, Jose M Gallardo, Rosa M Corrales, Angel Carracedo.   

Abstract

OBJECTIVE: To assess the genetic contribution to proliferative vitreoretinopathy (PVR) and report the strong association observed in the tumor necrosis factor (TNF) locus.
DESIGN: As a component of The Retina 4 Project, a case-controlled, candidate gene association study in the TNF locus was conducted. PARTICIPANTS AND CONTROLS: Blood from 450 patients with (138 cases) and without (312 controls) post-rhegmatogenous retinal detachment (RD) PVR was genotyped to determine polymorphisms located in the TNFα gene.
METHODS: Single nucleotide polymorphisms (SNPs) with correlation coefficients of ≥ 0.8 and a minor allelic frequency of ≥ 10% were studied. Functional SNPs or SNPs previously described in association with other inflammatory diseases were also added for analysis. The SNPlex Genotyping System (Applied Biosystems, Foster City, CA) was used for genotyping. Single nucleotide polymorphism and haplotype analyses were performed. Bioinformatic tools were used to evaluate those SNPs that were significantly associated. MAIN OUTCOME MEASURES: Single and haplotypic significant associations with PVR.
RESULTS: A total of 11 common tag SNPs in the following genes were analyzed: lymphotoxin alpha (LTA), TNFα, leukocyte-specific transcript 1 (LST1), and the activating natural killer receptor p30 (NCR3). After permutation, there was a significant association in the non-synonymous polymorphism rs2229094(T→C) in the LTA gene (P = 0.0283), which encodes a cysteine to arginine change in the signal peptide. This marker was also present in all significant haplotypic associations and was not observed in any nonsignificant associations. When this SNP was analyzed using bioinformatic tools, the hydropathy profile changed, as well as the transmembrane region and the splicing site predictions.
CONCLUSIONS: The strong association found in the rs2229094(T→C) of the LTA gene may indicate an important role of this polymorphism in the development of PVR. If supported in extended studies, the rs2229094(T→C) may have significant implications regarding the genetic risk of the retinal repairing process.
Copyright © 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20663564     DOI: 10.1016/j.ophtha.2010.03.059

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  19 in total

Review 1.  THE PATHOGENY OF PROLIFERATIVE VITREORETINOPATHY.

Authors:  Danielescu Ciprian
Journal:  Rom J Ophthalmol       Date:  2015 Apr-Jun

2.  Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy.

Authors:  B N M K Khanum; R Guha; V P Sur; S Nandi; S K Basak; A Konar; S Hazra
Journal:  Eye (Lond)       Date:  2017-03-17       Impact factor: 3.775

3.  Cytokine gene associations with self-report ratings of morning and evening fatigue in oncology patients and their family caregivers.

Authors:  Anand Dhruva; Bradley E Aouizerat; Bruce Cooper; Steven M Paul; Marylin Dodd; Claudia West; William Wara; Kathryn Lee; Laura B Dunn; Dale J Langford; John D Merriman; Christina Baggott; Janine Cataldo; Christine Ritchie; Kord M Kober; Heather Leutwyler; Christine Miaskowski
Journal:  Biol Res Nurs       Date:  2014-05-27       Impact factor: 2.522

4.  Inflammatory genes and psychological factors predict induced shoulder pain phenotype.

Authors:  Steven Z George; Jeffrey J Parr; Margaret R Wallace; Samuel S Wu; Paul A Borsa; Yunfeng Dai; Roger B Fillingim
Journal:  Med Sci Sports Exerc       Date:  2014-10       Impact factor: 5.411

5.  Structure of tumor necrosis factor-alpha haploblocks in European populations.

Authors:  Aimee M Merino; Kui Zhang; Richard A Kaslow; Brahim Aissani
Journal:  Immunogenetics       Date:  2013-04-12       Impact factor: 2.846

Review 6.  [Proliferative vitreoretinopathy process-To heal or not to heal].

Authors:  S Grisanti; S Priglinger; L Hattenbach
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

7.  Proliferative vitreoretinopathy and genetic profile.

Authors:  Khalil Ghasemi Falavarjani
Journal:  J Ophthalmic Vis Res       Date:  2013-01

8.  Comparison of gene expression profile of epiretinal membranes obtained from eyes with proliferative vitreoretinopathy to that of secondary epiretinal membranes.

Authors:  Ryo Asato; Shigeo Yoshida; Atsushi Ogura; Takahito Nakama; Keijiro Ishikawa; Shintaro Nakao; Yukio Sassa; Hiroshi Enaida; Yuji Oshima; Kazuho Ikeo; Takashi Gojobori; Toshihiro Kono; Tatsuro Ishibashi
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

Review 9.  Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside.

Authors:  Stavros N Moysidis; Aristomenis Thanos; Demetrios G Vavvas
Journal:  Mediators Inflamm       Date:  2012-09-25       Impact factor: 4.711

Review 10.  Proliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloid.

Authors:  Francesco Morescalchi; Sarah Duse; Elena Gambicorti; Mario R Romano; Ciro Costagliola; Francesco Semeraro
Journal:  Mediators Inflamm       Date:  2013-09-30       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.